{"filing":{"accession_number":"0001839341-26-000021","cik":"0001839341","ticker":"CORZZ","company_name":"Core Scientific, Inc./tx","form":"8-K","filing_date":"2026-08-27","report_date":"2026-08-25","primary_document":"core-20260825.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1839341/000183934126000021/core-20260825.htm"},"events":[{"id":29896,"run_id":27392,"accession_number":"0001839341-26-000021","anchor_item_number":"1.01","event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"Core Scientific entered into a $600 million senior secured credit facility on August 25, 2026, consisting of a $100 million revolving credit facility and a $500 million letter of credit facility, secured by substantially all assets of the Company and its subsidiaries. The facilities are expected to release approximately $300 million of restricted cash, materially improving the Company's capital efficiency and financial flexibility.","company_name":"Core Scientific, Inc./tx","ticker":"CORZZ","filing_date":"2026-08-27","form":"8-K","submitted_at":null,"items":[{"id":32321,"accession_number":"0001839341-26-000021","item_number":"1.01","item_title":"Entry into a Material Definitive Agreement.","event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Core Scientific entered into a $600 million senior secured credit facility on August 25, 2026, consisting of a $100 million revolving credit facility and a $500 million letter of credit facility. This represents the creation of new direct financial obligations secured by substantially all assets of the Company and its subsidiaries. The press release notes the facilities are \"expected to release approximately $300 million of restricted cash, meaningfully improving our capital efficiency and financial flexibility,\" indicating material financial impact. This is a classic debt issuance disclosure under Item 1.01.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-27T11:10:00.929279+00:00","company_name":"","ticker":null,"filing_date":""},{"id":32322,"accession_number":"0001839341-26-000021","item_number":"2.03","item_title":"Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.","event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Core Scientific entered into $600 million of committed senior secured credit facilities, consisting of a $100 million revolving credit facility and $500 million letter of credit facility. This represents the creation of new direct financial obligations secured by substantially all assets of the Company. The filing explicitly references Item 2.03 (Creation of a Direct Financial Obligation), and the press release details the terms, arrangers, and expected use of proceeds, including release of approximately $300 million of restricted cash.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-27T11:10:00.929279+00:00","company_name":"","ticker":null,"filing_date":""},{"id":32323,"accession_number":"0001839341-26-000021","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Core Scientific announced entry into $600 million of committed senior secured credit facilities, consisting of a $100 million revolving credit facility and $500 million letter of credit facility. This represents creation of new direct financial obligations with specified terms (SOFR plus 1.75%, three-year maturity), secured by substantially all assets. The disclosure explicitly states the facilities are expected to release approximately $300 million of restricted cash, materially improving capital efficiency and financial flexibility—a significant capital event for the company.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-27T11:10:00.929279+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":32321,"accession_number":"0001839341-26-000021","item_number":"1.01","item_title":"Entry into a Material Definitive Agreement.","event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Core Scientific entered into a $600 million senior secured credit facility on August 25, 2026, consisting of a $100 million revolving credit facility and a $500 million letter of credit facility. This represents the creation of new direct financial obligations secured by substantially all assets of the Company and its subsidiaries. The press release notes the facilities are \"expected to release approximately $300 million of restricted cash, meaningfully improving our capital efficiency and financial flexibility,\" indicating material financial impact. This is a classic debt issuance disclosure under Item 1.01.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-27T11:10:00.929279+00:00","company_name":"Core Scientific, Inc./tx","ticker":"CORZZ","filing_date":"2026-08-27"},{"id":32322,"accession_number":"0001839341-26-000021","item_number":"2.03","item_title":"Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.","event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Core Scientific entered into $600 million of committed senior secured credit facilities, consisting of a $100 million revolving credit facility and $500 million letter of credit facility. This represents the creation of new direct financial obligations secured by substantially all assets of the Company. The filing explicitly references Item 2.03 (Creation of a Direct Financial Obligation), and the press release details the terms, arrangers, and expected use of proceeds, including release of approximately $300 million of restricted cash.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-27T11:10:00.929279+00:00","company_name":"Core Scientific, Inc./tx","ticker":"CORZZ","filing_date":"2026-08-27"},{"id":32323,"accession_number":"0001839341-26-000021","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Core Scientific announced entry into $600 million of committed senior secured credit facilities, consisting of a $100 million revolving credit facility and $500 million letter of credit facility. This represents creation of new direct financial obligations with specified terms (SOFR plus 1.75%, three-year maturity), secured by substantially all assets. The disclosure explicitly states the facilities are expected to release approximately $300 million of restricted cash, materially improving capital efficiency and financial flexibility—a significant capital event for the company.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-27T11:10:00.929279+00:00","company_name":"Core Scientific, Inc./tx","ticker":"CORZZ","filing_date":"2026-08-27"}]}